Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

1.6K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.6K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

885
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
885
Allergic Reactions02:06

Allergic Reactions

31.4K
Overview
31.4K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.0K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.3K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.3K
Drugs Used in Upper Respiratory Disorders: Overview01:16

Drugs Used in Upper Respiratory Disorders: Overview

511
Upper respiratory tract disorders, including viral infections and allergic rhinitis, cause significant discomfort and disrupt daily life. Managing these conditions involves a variety of drugs, such as antihistamines, intranasal steroids, decongestants, antitussives, expectorants, and mucolytics. Specific examples of drugs in each category are provided.
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
511

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and Safety of Dupilumab in Chinese Adult Patients With Chronic Rhinosinusitis With Nasal Polyps: A Randomized, Placebo-Controlled, Phase III Trial.

Allergy·2026
Same author

AI-Based Quantitative Nasal Cytology for Predicting Eosinophilic Chronic Rhinosinusitis With Nasal Polyps: A Pilot Study.

International forum of allergy & rhinology·2026
Same author

Lower Airway Conditions Contribute to the Prediction of Polyp Recurrence in Chronic Rhinosinusitis With Nasal Polyps and Comorbid Asthma.

International forum of allergy & rhinology·2026
Same author

Prevalence and influencing factors of allergic rhinitis in Xi'an: A 2022 survey.

Asia Pacific allergy·2026
Same author

Pollen-Pharmacotherapy Interaction Impacts Symptom Control in Seasonal Allergic Rhinitis.

Allergy·2026
Same author

Increased Risk of Allergic Rhinitis Among Coal Mine Workers: A Cross-Sectional Study.

Laryngoscope investigative otolaryngology·2026
Same journal

Dendritic Cell α-Ketoglutarate Regulates Tfh Polarization in Allergy.

Allergy·2026
Same journal

Decoding the "Metallic" Immune Imprint: Single-Cell Exposomics Reveals the Immune Imprint of Fire Smoke.

Allergy·2026
Same journal

Immunonutrition in Early Life: The Role of Complementary Feeding, Dietary Patterns, and Nutritional Exposures on the Health of Young Children-An EAACI Scoping Review.

Allergy·2026
Same journal

Detergent-Containing Toothpaste Decreases Esophageal Mucosal Impedance and Alters Salivary Properties in Humans.

Allergy·2026
Same journal

Global Variation in Timing of Allergenic Food Introduction for Food Allergy Prevention: An International Survey of Healthcare Professionals.

Allergy·2026
Same journal

Deficiency of Mitochondrial Fatty Acid Enzyme, CPT1A, Underlies Airway Epithelial Barrier Dysfunction in Severe Asthma.

Allergy·2026
See all related articles

Related Experiment Video

Updated: Dec 9, 2025

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

2.3K

Advances and novel developments in allergic rhinitis.

Yifan Meng1,2, Chengshuo Wang1,2, Luo Zhang1,2,3,4

  • 1Department of Otolaryngology Head and Neck Surgery, Beijing TongRen Hospital, Capital Medical University, Beijing, China.

Allergy
|September 9, 2020
PubMed
Summary
This summary is machine-generated.

Allergic rhinitis (AR) research is advancing, exploring environmental factors, proteins, and cells in its development. New treatments like immunotherapy and biologics offer promising therapeutic options for this common upper airway disease.

Keywords:
allergic rhinitisbiologicsmechanismstreatment

More Related Videos

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

1.1K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.8K

Related Experiment Videos

Last Updated: Dec 9, 2025

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
06:08

Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence

Published on: September 22, 2023

2.3K
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

1.1K
Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber
08:47

Symptom Assessment of Patients with Allergic Rhinitis Using an Allergen Exposure Chamber

Published on: March 3, 2023

2.8K

Area of Science:

  • Immunology
  • Otorhinolaryngology
  • Environmental Health

Background:

  • Allergic rhinitis (AR) is a prevalent upper airway disease globally.
  • Current understanding of AR pathogenesis and treatment requires further investigation.
  • Novel insights into AR mechanisms and therapies are emerging from recent research.

Purpose of the Study:

  • To review recent literature on novel mechanisms in allergic rhinitis pathogenesis.
  • To highlight emerging therapeutic strategies for allergic rhinitis.
  • To synthesize current knowledge on environmental factors, proteins, cells, immunotherapy, and biologics in AR.

Main Methods:

  • Literature review of recently published papers on allergic rhinitis.
  • Analysis of studies focusing on environmental factors, proteins, and cells in AR development.
  • Evaluation of research on immunotherapy and biologic agents for AR treatment.

Main Results:

  • Recent studies identify key environmental influences, proteins, and cells contributing to AR.
  • Immunotherapy and biologic treatments show potential for managing allergic rhinitis.
  • The review consolidates new findings on AR pathogenesis and therapeutic advancements.

Conclusions:

  • Further research is needed to fully elucidate AR mechanisms.
  • Novel treatments, including immunotherapy and biologics, represent significant progress in AR management.
  • Understanding the interplay of environmental factors and biological components is crucial for effective AR control.